Position in ZTS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$286,622,087
-$87,673,444 QoQ
Shares Held
3,988,618
+26.0% QoQ
Ownership
0.965%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#18
of 1,408 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Amundi holds $594,123,116 across 28 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (48.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
3,988,618 | $286,622,087 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
219,094 | $118,711,701 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,929,853 | $65,383,418 | |
| 4 | VTRS |
Viatris Inc
|
3,269,550 | $51,920,453 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
220,463 | $37,156,833 | |
| 6 | ALKS |
Alkermes plc.
|
217,739 | $11,409,523 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
82,089 | $9,106,952 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
31,793 | $2,631,824 |
All Filings in ZTS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $286,622,087 | 3,988,618 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $374,295,531 | 3,166,361 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $503,445,702 | 4,001,317 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $387,270,409 | 2,646,736 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $428,552,312 | 2,748,011 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $592,020,142 | 3,595,628 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $447,848,777 | 2,748,719 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $367,456,237 | 1,880,726 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $323,618,213 | 1,866,741 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $369,764,961 | 2,185,243 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $408,211,485 | 2,068,255 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $315,150,151 | 1,811,416 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $313,324,205 | 1,819,431 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $300,252,262 | 1,803,967 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $310,049,089 | 2,115,654 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $300,099,511 | 2,023,734 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $263,040,335 | 1,530,283 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $279,862,084 | 1,483,971 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $298,927,956 | 1,224,964 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $316,229,984 | 1,628,876 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $321,789,852 | 1,726,711 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||